UConn studies human somatic cell genome editing

Human somatic cell genome editing  is a promising treatment option for cardiovascular disorders, but concerns remain about the safety and efficacy of this therapeutic strategy.

Joint faculty member at UConn Health and The Jackson Laboratory for Genomic Medicine, Dr. John Travis Hinson is principle investigator for a nearly $3 million grant from the National Institutes of Health to develop a pre-clinical model that can better assess these risks. more